Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Eton Pharmaceuticals (ETON) Non Operating Income: 2018-2024

Historic Non Operating Income for Eton Pharmaceuticals (ETON) over the last 7 years, with Dec 2024 value amounting to -$1.2 million.

  • Eton Pharmaceuticals' Non Operating Income fell 7025.00% to -$1.1 million in Q4 2024 from the same period last year, while for Dec 2024 it was -$1.2 million, marking a year-over-year decrease of 340.76%. This contributed to the annual value of -$1.2 million for FY2024, which is 340.76% down from last year.
  • Eton Pharmaceuticals' Non Operating Income amounted to -$1.2 million in FY2024, which was down 340.76% from $503,000 recorded in FY2023.
  • Eton Pharmaceuticals' 5-year Non Operating Income high stood at $503,000 for FY2023, and its period low was -$1.2 million during FY2024.
  • In the last 3 years, Eton Pharmaceuticals' Non Operating Income had a median value of -$761,000 in 2022 and averaged -$489,667.
  • Its Non Operating Income has fluctuated over the past 5 years, first slumped by 405.69% in 2020, then spiked by 166.10% in 2023.
  • Yearly analysis of 5 years shows Eton Pharmaceuticals' Non Operating Income stood at -$859,000 in 2020, then dropped by 17.11% to -$1.0 million in 2021, then increased by 24.35% to -$761,000 in 2022, then spiked by 166.10% to $503,000 in 2023, then slumped by 340.76% to -$1.2 million in 2024.